The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABCELLERA BIOLOGICS INC COM 00288U106 215,978 9,817,190 SH   DFND 1 9,817,190 0 0
ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 50,666 1,240,000 SH   DFND 1 1,240,000 0 0
AMAZON COM INC COM 023135106 5,653,275 1,643,426 SH   DFND 1 1,643,426 0 0
AURORA ACQUISITION CORP UNIT 03/02/2026 G0698L111 28,134 2,700,000 SH   DFND 1 2,700,000 0 0
BRIDGETOWN 2 HOLDINGS LTD CL A G1355V103 5,100 500,000 SH   DFND 1 500,000 0 0
CM LIFE SCIENCES II INC UNIT 02/25/2028 125842203 5,530 411,151 SH   DFND 1 411,151 0 0
CM LIFE SCIENCES INC COM CL A 18978W109 59,258 4,229,704 SH   DFND 1 4,229,704 0 0
CM LIFE SCIENCES III INC CLASS A COM 125841106 41,280 4,000,000 SH   DFND 1 4,000,000 0 0
CM LIFE SCIENCES III INC *W EXP 04/30/202 125841114 2,064 800,000 SH Call DFND 1 800,000 0 0
COMPUTE HEALTH ACQUISITIN CO COM CL A 204833107 39,280 4,000,000 SH   DFND 1 4,000,000 0 0
COMPUTE HEALTH ACQUISITIN CO *W EXP 01/25/202 204833115 1,510 1,000,000 SH Call DFND 1 1,000,000 0 0
ELLIOTT OPPORTUNITY II CORP UNIT 99/99/9999 G30092129 49,550 4,950,000 SH   DFND 1 4,950,000 0 0
FTAC ATHENA ACQUISITION CORP CL A SHS G37283101 19,720 2,000,000 SH   DFND 1 2,000,000 0 0
FTAC ATHENA ACQUISITION CORP *W EXP 03/01/202 G37283119 750 500,000 SH Call DFND 1 500,000 0 0
GRAPHITE BIO INC COM 38870X104 30,527 993,402 SH   DFND 1 993,402 0 0
FTAC HERA ACQUISITION CORP CLASS A ORD SHS G3728Y103 48,750 5,000,000 SH   DFND 1 5,000,000 0 0
FTAC HERA ACQUISITION CORP *W EXP 02/28/202 G3728Y111 1,650 1,250,000 SH Call DFND 1 1,250,000 0 0
CENTURY THERAPEUTICS INC COM 15673T100 58,680 2,000,000 SH   DFND 1 2,000,000 0 0
IRONSOURCE LTD CL A ORD SHS M5R75Y101 52,500 5,000,000 SH   DFND 1 5,000,000 0 0
KHOSLA VENTURES ACQUISITION CL A 482504107 14,835 1,500,000 SH   DFND 1 1,500,000 0 0
KHOSLA VENTURES ACQUSTN CO I COM CL A 482505104 34,791 3,500,000 SH   DFND 1 3,500,000 0 0
KHOSLA VENTURES ACQUT CO III COM CL A 482506102 39,480 4,000,000 SH   DFND 1 4,000,000 0 0
LYELL IMMUNOPHARMA INC COM 55083R104 56,840 3,500,000 SH   DFND 1 3,500,000 0 0
PACIFIC BIOSCIENCES CALIF IN COM 69404D108 344,842 9,861,089 SH   DFND 1 9,861,089 0 0
PIONEER MERGER CORP *W EXP 01/07/202 G7S24C111 1,476 916,666 SH Call DFND 1 916,666 0 0
PAYPAL HLDGS INC COM 70450Y103 702,296 2,409,413 SH   DFND 1 2,409,413 0 0
REVOLUTION HEALTHCAR AQ CORP CLASS A COM 76155Y108 29,460 3,000,000 SH   DFND 1 3,000,000 0 0
REVOLUTION HEALTHCAR AQ CORP *W EXP 12/31/202 76155Y116 846 600,000 SH Call DFND 1 600,000 0 0
SANA BIOTECHNOLOGY INC COM 799566104 51,611 2,625,153 SH   DFND 1 2,625,153 0 0
SVF INVESTMENT CORP UNIT 12/20/2025 G8601L110 22,374 2,200,000 SH   DFND 1 2,200,000 0 0
SVF INVESTMENT CORP 2 CL A SHS G8601M100 9,950 1,000,000 SH   DFND 1 1,000,000 0 0
SVF INVESTMENT CORP 3 CL A SHS G8601N108 19,880 2,000,000 SH   DFND 1 2,000,000 0 0
TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS 874039100 811,575 6,754,120 SH   DFND 1 6,754,120 0 0